Drug Trial News

RSS
Nicotinamide riboside shows promise in treating Werner syndrome symptoms

Nicotinamide riboside shows promise in treating Werner syndrome symptoms

New data shows zigakibart sustains proteinuria remission and kidney function in IgA nephropathy

New data shows zigakibart sustains proteinuria remission and kidney function in IgA nephropathy

P2Y12 inhibitors linked to lower rates of cardiovascular events compared to aspirin

P2Y12 inhibitors linked to lower rates of cardiovascular events compared to aspirin

Type 2 diabetes drug shows improvements for patients with progressive liver disease

Type 2 diabetes drug shows improvements for patients with progressive liver disease

AI-designed drug shows early promise for lung fibrosis patients in clinical trial

AI-designed drug shows early promise for lung fibrosis patients in clinical trial

SWOG S2302 Pragmatica-Lung study demonstrates value of streamlined clinical trials in real world settings

SWOG S2302 Pragmatica-Lung study demonstrates value of streamlined clinical trials in real world settings

Early camizestrant therapy keeps advanced breast cancer in check

Early camizestrant therapy keeps advanced breast cancer in check

Real world data confirms effectiveness of nirsevimab in young infants with bronchiolitis

Real world data confirms effectiveness of nirsevimab in young infants with bronchiolitis

PfSPZ-LARC2 malaria vaccine advances to new age groups after successful safety review

PfSPZ-LARC2 malaria vaccine advances to new age groups after successful safety review

Asthma drug once hoped to treat alcohol use disorder fails to meet expectations in UCLA trial

Asthma drug once hoped to treat alcohol use disorder fails to meet expectations in UCLA trial

THP regimen achieves high response rates in HER2 positive breast cancer patients

THP regimen achieves high response rates in HER2 positive breast cancer patients

First-in-class antibody-drug conjugate shows high response rates in rare blood cancer trial

First-in-class antibody-drug conjugate shows high response rates in rare blood cancer trial

Immunotherapy before surgery boosts long term survival in lung cancer, trial shows

Immunotherapy before surgery boosts long term survival in lung cancer, trial shows

Treatment switching guided by liquid biopsy results improves outcomes in advanced breast cancer

Treatment switching guided by liquid biopsy results improves outcomes in advanced breast cancer

Adding immunotherapy to chemotherapy after surgery improves survival in colon cancer

Adding immunotherapy to chemotherapy after surgery improves survival in colon cancer

Avelumab and cetuximab combination shows promise in phase II skin cancer trial

Avelumab and cetuximab combination shows promise in phase II skin cancer trial

Dual-target CAR T cell therapy shrinks tumors in aggressive brain cancer

Dual-target CAR T cell therapy shrinks tumors in aggressive brain cancer

Combination treatment extends progression-free survival in advanced skin cancer

Combination treatment extends progression-free survival in advanced skin cancer

Universal CAR T cell therapy shows promise for aggressive T cell cancers

Universal CAR T cell therapy shows promise for aggressive T cell cancers

Triplet therapy significantly improves survival in BRAF V600E-mutated metastatic colorectal cancer

Triplet therapy significantly improves survival in BRAF V600E-mutated metastatic colorectal cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.